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Background. Lung transplant remains the only viable treatment for most of the end-stage
lung diseases. It is believed that extending criteria for donor lungs would increase the
number of lung transplants. The aim of the study was to compare the graft function by
means of oxygenation index among recipients who received the lungs from donors of
extended criteria with those whose received lungs from donors who met the standard
criteria.
Methods. This retrospective study analyzed 71 donors whose lungs where transplanted
into 71 first-time double lung recipients of 2 groups: patients who received transplants
before and after 2018. The objective was to assess whether there is a significant difference
in quality of the donor pool after applying extended criteria. The second objective was to
compare results of recipients with lungs from donors of oxygenation index > 400 mm Hg
with those obtained among recipients with this parameter < 400 mm Hg.
Results. In the case of transplants performed in 2018 to 2019, oxygenation indices were
significantly lower in donors but significantly higher in recipients on the first day than those
observed in 2015 to 2017. The number of transplants increased from 9 per year to 22 per
year. Irrespective of whether the donor had PaO2/fraction of inspired oxygen above or
below 400 mm Hg, recipients showed similar oxygenation index values after transplant
(mean oxygenation index, 462 vs 412 mm Hg, respectively). Short-term mortality did not
differ either.
Conclusions. Extended criteria of lungs suitability as a potential grafts not only increases
the donor pool but also proves that suboptimal donors are not associated with producing
inferior results of the recipients.Disclosures: none
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International Heart and Lung Registry, more than 69,000
adult lung transplants have been performed in 260 lung
transplant centers so far [1]. The number of lung transplants
in Poland has increased over the years, reaching 43 in 2018.
However, the Polish National Transplantation Registry re-
ports that the number of the procured lungs the same year
was 52, meaning that some of those organs were not used.
This issue is important as the National Registry also reportsAuthors. Published by Elsevier Inc. This is an open
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Table 1. General Characteristics With Demographic and Clinical
Features of the Entire Study Group
All Patients (n ¼ 71) 2015-2019
Recipient age, median (IQR) 35 (28)
Recipient BMI, median (IQR) 18 (4)
Donor age, mean (SD), y 43.12 (12)
Donor BMI, mean (SD) 24.12 (3)
Recipient pulmonary function at qualification
FEV1, median (IQR), % 24 (17)
FVC, mean (SD), % 46.84 (19)
6MWD, median (IQR), m 323.1 (247.5)
Oxygenation index, mean (SD), mm Hg 462.37 (77)
Donor hemoglobin, mean (SD), g% 10.96 (3)
Donor serum creatinine, median (IQR), mg% 1.1 (0.88)
Recipient length of hospital stay, median (IQR), d 41 (22)
Duration of operation, median (IQR), h 12.92 (2.34)
Ventilation time, median (IQR), h 24.8 (8.25)
Total ischemic time, mean (SD), min 754 (472)
Recipient sex, No. (%)
Female 35 (49.3)
Male 36 (50.7)
Donor sex, No. (%)
Female 32 (45.07)
Male 39 (54.93)





Underlying disease, No. (%)
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Contrary to those unsettling trends, there is also a steady
increase in multiorgan procurements in Poland (73% of all
solid organ procurements performed in Poland in 2018).
Such data indicate that extending a donor pool seems
necessary. Certain criteria are believed to be describing the
perfect lung donor, for example, age younger than 55 years,
clear chest radiograph, arterial oxygen tension/fraction of
inspired oxygen e oxygenation index (PaO2/fraction of
inspired oxygen [FiO2]) > 300 mm Hg at positive end-
expiratory pressure ¼ 5 cm H2O, less than 20 packs/y
smoking history, absence of chest trauma, and purulent se-
cretions on bronchoscopic visualization prior to procuring
the lungs. Unfortunately, such donors are pretty uncommon
[3]. Although oxygenation index exceeding 300 mm Hg
provides satisfactory outcomes of lung transplant, the
threshold for accepting the donor lungs in the biggest lung
transplant facility was PaO2/FiO2 > 400 mm Hg until the
year 2018. Since then, the aforementioned parameter was
evaluated as less significant; therefore, the strict data-based
approach, when it comes to lung assessment, was replaced
with a more clinically led one. The aim of the study was to
assess the graft function by means of oxygenation index at 3
time points: PaO2/FiO2 at official reporting of the available
donor, first PaO2/FiO2 obtained after the procedure, and
first PaO2/FiO2 after 24 hours since the end of the pro-
cedure among patients who underwent double lung trans-
plant in a single center.Chronic obstructive pulmonary disease 8 (11.27)
Cystic fibrosis 39 (54.92)
Idiopathic pulmonary fibrosis 2 (2.82)
Interstitial lung disease (other than IPF) 5 (7.05)
Idiopathic pulmonary arterial hypertension 5 (7.05)
Combined pulmonary fibrosis and emphysema 1 (1.41)




Hypersensitivity pneumonitis 2 (2.82)
Langerhans cell histiocytosis 1 (1.41)
Hereditary hemorrhagic telangiectasia 1 (1.41)
Abbreviations: 6MWD, 6-minute walk distance; BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared; FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity; IQR, inter-
quartile range; IPF, idiopathic pulmonary fibrosis.MATERIALS AND METHODS
This retrospective study analyzed 71 donors whose lungs where
transplanted into 71 first-time double lung recipients. Inclusion
criteria were as follows: primary double lung transplant procedure,
performed between January 1, 2015, and December 31, 2017 (group
1: 27 patients) and between January 1, 2018, and November 30,
2019 (group 2: 44 patients) in Silesian Center for Heart Diseases.
Patients who received transplants before 2015 as well as those who
underwent single lung transplant, underwent retransplant, or did
not survive the procedure were excluded from the study. Detailed
demographic and clinical characteristics of studied donor-recipient
pairings are presented in Table 1. The first objective was to assess
whether there is a significant difference in quality of the donor pool,
measured by mean oxygenation index of the given period and how it
affected the PaO2/FiO2 at the 2 remaining recipient-associated time
points. The second objective was to evaluate the quality of the lungs
by means of oxygenation index after the transplant for those who
had received the double lung graft of PaO2/FiO2 > 400 mm Hg at
reporting of the donor. The third objective was to compare afore-
mentioned results with those obtained among recipients with donor
oxygenation index < 400 mm Hg. The second and third objectives
were performed only among patients from group 2 with available
data (n ¼ 32). Detailed demographic and clinical characteristics of
this particular donor-recipient pairings are presented in Table 2.
Statistical Analysis
Data with normal distribution were presented as mean and standard
deviation. Data not presenting the normal distribution were pre-
sented as median and interquartile range. Statistical analyses werecarried out using the TIBCO Statistica 13.3 software (TIBCO
Software, Palo Alto, Calif, United States). With its use, basic
descriptive statistics were analyzed along with Shapiro-Wilk tests as
well as Student t test analysis for independent samples and the
Mann-Whitney U test. The classic threshold a ¼ .05 was considered
the level of significance.RESULTS
Comparison of Donor and Recipient Oxygenation Index
Depending on the Year of Surgery
The first assessment was to determine how the oxygenation
indices of donors and recipients differ for procedures
Table 2. Donor and Recipient Demographic and Clinical
Features Among Patients Who Underwent Double Lung
Transplant Between 2018-2019, Divided Into Groups According
to Donor Oxygenation Index
Variables > 400 mm Hg  400 mm Hg
P
Value
Recipient age, mean (SD), y 39 (14) 37.5 (14) .732
Recipient BMI, mean (SD) 18.19 (3) 19.21 (4) .365
Donor age, mean (SD), y 43.11 (16) 44.75 (10) .686
Donor BMI, mean (SD)] 23.99 (3) 24.33 (3) .714
Recipient pulmonary function at
qualification
FEV1, mean (SD), % 22.26 (7) 30.04 (15) .098
FVC, mean (SD), % 43.9 (17) 49.41 (22) .577
6MWD, mean (SD), m 274.85 (166) 353.94 (160) .254
Donor hemoglobin, mean (SD), g
%
11.56 (3) 11.18 (3) .725
Donor serum creatinine, median
(IQR), mg%
0.97 (0.63) 1.05 (0.82) .886
Duration of operation, median
(IQR), h
12.58 (2.34) 12.71 (3.75) .765
Ventilation time, median (IQR), h 28.58 (62.59) 26 (29.83) .396
Total ischemic time, mean (SD),
min
596.73 (469) 821.14 (488) .217
Recipient sex, No. (%) .674
Female 14 (48.28) 4 (57.14)
Donor sex, No. (%) .125
Female 9 (31.03) 5 (71.42)
Underlying disease, No. (%) .846
Chronic obstructive pulmonary
disease
2 (6.90) 2 (28.57)
Cystic fibrosis 19 (65.52) 3 (42.86)
Interstitial lung disease (other
than IPF)
3 (10.35) 1 (14.28)
Idiopathic pulmonary arterial
hypertension
1 (3.457) 0 (0)
Emphysema 2 (6.90) 0 (0)
Bronchiectasis 1 (3.45) 0 (0)
Pneumoconiosis 0 (0) 1 (14.29)
Hypersensitivity pneumonitis 1 (3.45) 0 (0)
Abbreviations: 6MWD, 6-minute walk distance; BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared; FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity; IPF, idiopathic
pulmonary fibrosis; IQR, interquartile range.
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(group 2). Analyses were performed using the Student t test
for independent samples, comparing the PaO2/FiO2 of the
donor (first time point) and recipient (second time point) in
the mentioned groups. The analysis was performed only onTable 3. Comparison of Donor and recipient oxygenatio
Variable
2015-2017 (n ¼ 27) 2018-2
Mean SD Mean
Donor PaO2/FiO2 (first time point) 487.13 72.37 447.51
Recipient PaO2/FiO2 (second time point) 323.02 114.97 473.21
Abbreviations: FiO2, fraction of inspired oxygen; LL, lower limit; UL, upper limit.patients who underwent double lung transplant, excluding
retransplant.
It showed that in the case of operations performed in
2018 to 2019, oxygenation rates were significantly lower in
donors while significantly higher in recipients on the first
day than those observed in 2015 to 2017. The strength of
dependence for donors was large and was very large for
recipients. Detailed results of this part of the study are
presented in Table 3.
Comparison of Recipient Oxygenation Index Depending on
Donor Oxygenation Index
Subsequently, it was analyzed how the recipient mean
oxygenation index differs among those who received trans-
plants between 2018 and 2019, depending on whether PaO2/
FiO2 was observed above or below 400 mm Hg in the donor.
Analyses were performed using Student t test for indepen-
dent samples, comparing the recipient oxygenation index
(on the first and second days) in these groups. The analysis
was performed only on patients who underwent double lung
transplant, excluding retransplant.
The results were not statistically significant. This means
that irrespective of whether the donor had PaO2/FiO2 above
or below 400 mm Hg, recipients showed similar oxygenation
index values both on the first and the following days.
Detailed results of this analysis are demonstrated in Table 4.
Extending the donor pool allowed more lungs to be
procured. Such change of approach led to increase of
double lung transplant from 9 per year to 22 per year and
counting. Replacing the strict oxygenation index policy from
previous years with the more liberal one alone led to
additional 7 double lung transplants between 2018
and 2019.
Short-term Mortality
One-year mortality among double lung recipients who
received transplants between 2015 and 2017 was approxi-
mately 18.75%. The same parameter among the patients
who received transplants in 2018 was 8.7%. All 7 patients
with PaO2/FiO2 of less than 400 mm Hg are alive at the time
of submitting this article (5 received transplants in 2018).
DISCUSSION
Ideal PaO2 (PaO2 > 300 mm Hg on FiO2 ¼ 1.0, positive
end-expiratory pressure ¼ 5 cm H2O) was believed to be the
most important factor to evaluate lung quality. Several re-
searches have shown that poor oxygenation index (PaO2/n indices (PaO2/FiO2) Depending on Year of Surgery
019 (n ¼ 44)
t P Value
95% CI
Cohen dSD LL UL
78.66 2.12 .037 3.01 76.23 0.88
244.13 3.33 .001 240.26 60.12 2.16
Table 4. Comparison of Recipient Oxygenation Indices Depending on Donor Oxygenation Index
Variables
> 400 mm Hg (n ¼
29) < 400 mm Hg (n ¼ 7)
t P Value
95% CI
Cohen dMean SD Mean SD LL UL
Recipient PaO2/FiO2 (second time point) 462.89 208.71 412.24 216.23 0.57 .571 154.30 255.59 0.27
Recipient PaO2/FiO2 (third time point) 429.41 165.80 454.53 153.37 0.25 .808 344.89 294.65 0.16
Abbreviations: FiO2, fraction of inspired oxygen; LL, lower limit; UL, upper limit.
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the donor [4,5]. First research assessing the issue of
oxygenation index dated back to 1995 [6]. Sundaresan et al
concluded that successful outcome of lung transplant can be
achieved with the use of marginal donor lungs. More data
were provided by the review article assessing more than
12,000 donors. Patients were divided into 3 groups: donor
PaO2/FiO2 greater than 300 mm Hg, PaO2/FiO2 201 to 300
mm Hg, and PaO2/FiO2 of less than 200 mm Hg. The
conclusion of the article was that donor oxygenation index
did not affect survival of graft recipients, and it may play
much less vital role that previously believed [4]. Dis-
qualifying a donor solely on this result seems irrational.
Sometimes, lower oxygenation index may be an effect of an
easily reversible process such as pulmonary edema or
retained secretion. Customized lung donor management
protocols (eg, diuresis, lung recruitment maneuvers) may
improve lungs functioning and help the donors to meet the
oxygenation requirement [7]. Nevertheless, harvesting and
transplanting the organs from donors with PaO2/FiO2 levels
lower than 300 mm Hg does not seem to affect the results of
the transplant in a negative way [8e10]. Another review
published by Schiavon et al also assesses marginal donors.
Its conclusion states that majority of articles report
comparably positive outcomes of lung transplant after
donation from donors of oxygenation index of less than 300
mm Hg [11]. On the other hand, the nonlinear model of
Thalbut et al showed a steep increase in the relative risk of
death when donor PaO2/FiO2 before harvest was below 350
mm Hg [12]. However, available data of more recent studies
and review assessing greater number of patients rule in
favor of extending the oxygenation index values as well as
taking a more liberal approach on its importance. All of
those findings were taken into consideration at the end of
2017 before it was decided to change the policy pertaining
the oxygenation index in our facility. Our results are
consistent with available literature that oxygenation index of
less than 400 mm Hg does not mean that the quality of the
lungs will provide worse function than those of PaO2/FiO2
exceeding 400 mm Hg. Our study also demonstrated that 5
of those 7 patients with oxygenation index of less than 400
mm Hg had mean PaO2/FiO2 of 310 mm Hg. All of the 7
patients are still alive up to this day; 5 of them reached1-year survival as they received transplants in 2018. What is
more, 2 of our recipients received lungs with PaO2/FiO2 less
than 300 mm Hg. Both reached 1-year survival and are in
general good condition.
CONCLUSIONS
A more liberal clinically based approach for assessment of
lung suitability as a potential graft not only increases the
donor pool but also proves that suboptimal donors are not
associated with producing inferior results for the recipients.
Moreover, short-term mortality of patients receiving lungs
of lesser oxygenation index of the donor at reporting does
not differ from those with supposedly better lungs among
double lung transplant recipients. This issue requires further
study on a larger group with increased follow-up time.
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